Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Reforming pharmaceutical industry-physician financial relationships: lessons from the United States, France, and Japan.

Authors
  • Rodwin, Marc A1
  • 1 Harvard University, USA.
Type
Published Article
Journal
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics
Publication Date
2011
Volume
39
Issue
4
Pages
662–670
Identifiers
DOI: 10.1111/j.1748-720X.2011.00633.x
PMID: 22084852
Source
Medline
License
Unknown

Abstract

This article compares the means that the United States, France, and Japan use to oversee pharmaceutical industry-physician financial relationships. These countries rely on professional and/or industry ethical codes, anti-kickback laws, and fair trade practice laws. They restrict kickbacks the most strictly, allow wide latitude on gifts, and generally permit drug firms to fund professional activities and associations. Consequently, to avoid legal liability, drug firms often replace kickbacks with gifts and grants. The paper concludes by proposing reforms that address problems that persist when firms replace kickbacks with gifts and grants based on the experience of the three countries.

Report this publication

Statistics

Seen <100 times